國立高雄大學圖資館 |

Language: English

Back

New drugs and targets for asthma and...

Barnes, Peter J., (1946-)

New drugs and targets for asthma and COPD

Record Type:	Electronic resources : Monograph/item
Title/Author:	New drugs and targets for asthma and COPDvolume editors, Trevor T. Hansel, Peter J. Barnes.
other author:	Hansel, T. T.
Published:	Basel :Karger,c2010.
Description:	1 online resource (xiv, 310 p.) :ill. (chiefly col.)
Subject:	AsthmaChemotherapy.
Online resource:	http://content.karger.com/produkteDB/produkte.asp?Aktion=ShowEachType&ProduktNr=254432
ISBN:	9783805595674 (electronic bk.)

New drugs and targets for asthma and COPD
New drugs and targets for asthma and COPD[electronic resource] /volume editors, Trevor T. Hansel, Peter J. Barnes. - Basel :Karger,c2010. - 1 online resource (xiv, 310 p.) :ill. (chiefly col.) - Progress in respiratory research,v. 391422-2140 ;. - Progress in respiratory research ;v.37..

Includes bibliographical references and index.

Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists.

ISBN: 9783805595674 (electronic bk.)Subjects--Topical Terms:

569462
Asthma
--Chemotherapy.Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RC591 / .N497 2010

Dewey Class. No.: 616.2/38061

National Library of Medicine Call No.: W1 / PR681DM v.39 2010

New drugs and targets for asthma and COPD
LDR:02123cmm a2200289 a 4500 001 341527
006 m d
007 cr cn|||||||||
008 120907s2010 sz ob 001 0 eng d
020 $a 9783805595674 (electronic bk.)
020 $a 3805595670 (electronic bk.)
020 $a 9786613439345
020 $a 6613439347
020 $a 9783805595667 (hc : alk. paper)
020 $a 3805595662 (hc : alk. paper)
035 $a ocn664346557
040 $a UKSKG $b eng $c UKSKG $d N $d CDX $d IDEBK $d E7B
050 4 $a RC591 $b .N497 2010
060 1 4 $a W1 $b PR681DM v.39 2010
060 1 4 $a WF 553
082 0 4 $a 616.2/38061 $2 22
245 0 0 $a New drugs and targets for asthma and COPD $h [electronic resource] / $c volume editors, Trevor T. Hansel, Peter J. Barnes.
260 $a Basel : $b Karger, $c c2010.
300 $a 1 online resource (xiv, 310 p.) : $b ill. (chiefly col.)
490 1 $a Progress in respiratory research, $x 1422-2140 ; $v v. 39
504 $a Includes bibliographical references and index.
520 $a Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists.
650 0 $a Asthma $x Chemotherapy. $3 569462
650 0 $a Antiasthmatic agents. $3 569463
650 1 2 $a Asthma $x drug therapy. $3 569464
650 2 2 $a Pulmonary Disease, Chronic Obstructive $x drug therapy. $3 301713
650 2 2 $a Respiratory System Agents. $3 569465
655 4 $a Electronic books. $2 local. $3 214472
700 1 $a Hansel, T. T. $q (Trevor T.), $d 1956- $3 569461
700 1 $a Barnes, Peter J., $d 1946- $3 504619
710 2 $a S. Karger (Firm) $3 569297
830 0 $a Progress in respiratory research ; $v v.37. $3 520833
856 4 0 $u http://content.karger.com/produkteDB/produkte.asp?Aktion=ShowEachType&ProduktNr=254432